Unraveling the mysteries of myelin
Kelly Monk, PhD, is one of the world’s foremost experts on the cells that form myelin, the protective sheath around axons that is damaged in diseases such as multiple sclerosis.
Kelly Monk, PhD, is one of the world’s foremost experts on the cells that form myelin, the protective sheath around axons that is damaged in diseases such as multiple sclerosis.
Dr. Gordon Mills is seeing outstanding early results in studies using cancer drugs in combination, like a one-two punch, to boost their effectiveness.
Meet three researchers at the OHSU Knight Cancer Institute — all united by the common goal of creating a world free from the burden of cancer.
Researchers at the Pediatric Brain Tumor Program discuss the urgent need for more targeted therapies for brain and spine tumors.
Eneida Nemecek, MD, MS, MBA, is a pediatric oncologist, researcher and professor who is determined to whittle the number of childhood cancers down.
Why do neurons die? That was what OHSU’s Marc Freeman wondered, years ago. Freeman — then a professor of neurobiology at the University of Massachusetts Medical School, and first and foremost a basic scientist — understood that traumatic brain injury, Alzheimer’s and Parkinson’s disease all result from the degeneration of neurons. But he wasn’t initially […]
A Q&A with Bree Mitchell, PhD, who leads strategic planning, scientific program development, organizational development, operations, and scientific collaboration building as the Associate Director of the OHSU Knight Cancer Institute’s Cancer Early Detection Advanced Research Center (CEDAR).
Scientists have long imagined how they could improve treatments for a host of diseases if they could better see how individual cells carry out the functions of life. That goal is now within reach at OHSU, thanks to a huge new investment in technology that allows researchers to view the makeup of molecules nearly down […]
The first time you meet Johnny Matheny is astonishing. You would be forgiven for wondering: can this be real? That’s because when Johnny reaches out to shake your hand, he’s extending his grasp with the world’s first mind-controlled robotic arm. He lost his arm to cancer, and what has replaced the missing limb is extraordinary. […]
Pictured Above: Achromatopsia clinical trial patient Annie Joiner. She’s seen the world throughout her life in black and white until a gene therapy clinical trial gave her a first glimpse of color. No one has looked at the colors on an iPhone with as much fascination as Annie Joiner has in the past couple of […]